Table of Contents

company-logo

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Sagimet Biosciences Dividend Announcement

• Sagimet Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Sagimet Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Sagimet Biosciences Dividend History

Sagimet Biosciences Dividend Yield

Sagimet Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Sagimet Biosciences stock? Use our calculator to estimate your expected dividend yield:

Sagimet Biosciences Financial Ratios

P/E ratio-4.22
PEG ratio-0.04
P/B ratio0.93
ROE-23.63%
Payout ratio0.00%
Current ratio38.41
Quick ratio38.41
Cash Ratio18.82

Sagimet Biosciences Dividend FAQ

Does Sagimet Biosciences stock pay dividends?
Sagimet Biosciences does not currently pay dividends to its shareholders.
Has Sagimet Biosciences ever paid a dividend?
No, Sagimet Biosciences has no a history of paying dividends to its shareholders. Sagimet Biosciences is not known for its dividend payments.
Why doesn't Sagimet Biosciences pay dividends?
There are several potential reasons why Sagimet Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Sagimet Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Sagimet Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Sagimet Biosciences a dividend aristocrat?
Sagimet Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Sagimet Biosciences a dividend king?
Sagimet Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Sagimet Biosciences a dividend stock?
No, Sagimet Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Sagimet Biosciences stocks?
To buy Sagimet Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Sagimet Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.